The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe (326047)
ARTG Name
ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe
Product name
ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
satralizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information